Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials
261 Downloads

Pin It on Pinterest

WordPress database error: [Table 'wp_fellowvision.wpyi_ai1ec_events' doesn't exist]
SELECT terms.name as category,terms.term_id as term_id, e.post_id,p.post_title, i.id AS instance_id, i.start AS START, i.end AS END FROM `wpyi_ai1ec_events` e INNER JOIN `wpyi_posts` p ON e.post_id = p.ID INNER JOIN `wpyi_ai1ec_event_instances` i ON e.post_id = i.post_id LEFT JOIN `wpyi_term_relationships` AS `term_relationships` ON (`e` . `post_id` = `term_relationships` . `object_id`) LEFT JOIN `wpyi_term_taxonomy` AS `term_taxonomy` ON (`term_relationships` . `term_taxonomy_id` = `term_taxonomy` . `term_taxonomy_id` AND `term_taxonomy` . taxonomy = 'events_categories') LEFT JOIN `wpyi_terms` AS `terms` ON (`terms` . `term_id` = `term_relationships` . `term_taxonomy_id`) WHERE post_type = 'ai1ec_event' AND i.end >= 1762696591 AND post_status IN ('publish', 'private') /* From [fellow.vision-relief.com/sdm_downloads/efficacy-durability-and-safety-of-intravitreal-faricimab-with-extended-dosing-up-to-every-16-weeks-in-patients-with-diabetic-macular-oedema-yosemite-and-rhine-two-randomized-double-masked-phase/] in [/nas/content/live/fellowvision/wp-content/themes/astra-child/inc/map-one.php:67] */

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers